Back to Journals » Drug Design, Development and Therapy » Volume 11
Original Research
Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H:quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,178 | Dovepress* | 9,296+ | 937 | 10,233 | |
PubMed Central* | 882 | 289 | 1,171 | ||
Totals | 10,178 | 1,226 | 11,404 | ||
*Since 7 November 2017 |
View citations on PubMed Central and Google Scholar